mebendazole has been researched along with secnidazole in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Hart, CJS; Riches, A; Skinner-Adams, TS; Trenholme, KR | 1 |
Almirall, P; Cañete, R; Cimerman, S; Escobedo, AA; Gonzalez, ME; Pareja, A | 1 |
Brito, K; Cañete, R; Herrera, E; Kofoed, PE; Noda, AL; Rodríguez, M; Ursing, J | 1 |
1 review(s) available for mebendazole and secnidazole
Article | Year |
---|---|
Anti-
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, Combination; Gastrointestinal Tract; Giardia; Giardiasis; Humans; Nitroimidazoles | 2020 |
1 trial(s) available for mebendazole and secnidazole
Article | Year |
---|---|
A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis.
Topics: Adolescent; Antiprotozoal Agents; Child; Child, Preschool; Feces; Female; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Treatment Outcome | 2003 |
1 other study(ies) available for mebendazole and secnidazole
Article | Year |
---|---|
5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
Topics: Adult; Aged; Antiprotozoal Agents; Cuba; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Feces; Female; Giardia lamblia; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Middle Aged; Nitroimidazoles; Prospective Studies; Quinacrine; Treatment Outcome; Young Adult | 2020 |